发明名称 |
1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-PIPERIDIN-1-YL]-XANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL |
摘要 |
The present invention provides a pharmaceutical composition comprising 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine or a pharmaceutically acceptable form thereof as pharmaceutically active compound for the therapy of a metabolic disorder or metabolic disease of a predominantly carnivorous non-human animal. It is especially useful for the therapy of diabetes and related diseases of predominantly carnivorous mammals like cats or dogs. The invention further provides respective uses of such compositions and of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine or pharmaceutically acceptable forms thereof.
|
申请公布号 |
US2011237532(A1) |
申请公布日期 |
2011.09.29 |
申请号 |
US201113072428 |
申请日期 |
2011.03.25 |
申请人 |
BOEHRINGER INGELHEIM VETMEDICA GMBH |
发明人 |
DE VRIES FRERICH;HOERSTERMANN DIRK;LANG INGO;MARK MICHAEL;SEIDLER RANDOLPH;THOMAS LEO |
分类号 |
A61K31/522;A61K31/7034;A61K31/7056;A61P1/18;A61P3/04;A61P3/06;A61P3/10;A61P5/48;A61P9/10;A61P29/00;C07D473/04 |
主分类号 |
A61K31/522 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|